Inotiv Inc
NASDAQ:NOTV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
TAL Education Group
NYSE:TAL
|
CN |
|
Inotiv Inc
NASDAQ:NOTV
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (29.2), the stock would be worth $-52.49 (17 517% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.2 | $0.3 |
0%
|
| Industry Average | 29.2 | $-52.49 |
-17 517%
|
| Country Average | 19.6 | $-35.3 |
-11 811%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
$4.5m
|
/ |
Jan 2026
$-35.4m
|
= |
|
|
$4.5m
|
/ |
Sep 2026
$-30.1m
|
= |
|
|
$4.5m
|
/ |
Sep 2027
$-14.9m
|
= |
|
|
$4.5m
|
/ |
Sep 2028
$95.5m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Inotiv Inc
NASDAQ:NOTV
|
10.4m USD | -0.2 | -0.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 2 361.7 | 4 280.5 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
193.4B USD | 24.2 | 25.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
130.1B USD | 25.9 | 34.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 39.4 | 46.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.9B CHF | 26.2 | -122.3 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
296.1B CNY | 16.2 | 15.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.1B USD | 21.8 | 25 | |
| US |
|
Waters Corp
NYSE:WAT
|
32.8B USD | 38.7 | 47.6 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.7B USD | 16.9 | 19.8 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.7B USD | 24 | 29 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 19.6 |
| 70th Percentile | 27.8 |
| Max | 1 826 183.2 |
Other Multiples
Inotiv Inc
Glance View
Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company is headquartered in West Lafayette, Indiana and currently employs 541 full-time employees. The firm focuses on providing drug developers with scientific research and analytical instrumentation. The firm operates through two segments, including Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance and quality control testing. The Research Products segment offers two principal product lines, including analytical products and in vivo sampling products. Analytical products consist of liquid chromatographic and electrochemical instruments with associated accessories. In vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments.
